Cheila Brito
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Increased Expression of HLA-DR and CD69 on Peripheral CD4+ T Cells Predicts Better Clinical Outcomes in Cutaneous Melanoma.
Journal: ImmunoTargets and therapy
Published: March 04, 2026
BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: June 06, 2023
PIK3CA Mutations in Diffuse Gliomas: An Update on Molecular Stratification, Prognosis, Recurrence, and Aggressiveness.
Journal: Clinical Medicine Insights. Oncology
Published: September 03, 2021
Unraveling the Relevance of ARL GTPases in Cutaneous Melanoma Prognosis through Integrated Bioinformatics Analysis.
Journal: International journal of molecular sciences
Published: July 28, 2021
The Impact of Olive Oil Compounds on the Metabolic Reprogramming of Cutaneous Melanoma Cell Models.
Journal: Molecules (Basel, Switzerland)
Published: October 31, 2020
Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness.
Journal: Frontiers in cell and developmental biology
Published: June 22, 2020
High-Throughput Sequencing Identifies 3 Novel Susceptibility Genes for Hereditary Melanoma.
Journal: Genes
Published: March 10, 2020
Melanoma Metabolism: Cell Survival and Resistance to Therapy.
Journal: Advances in experimental medicine and biology
Published: March 05, 2020
Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
Journal: BMC cancer
Published: April 01, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026